WO2002000897A3 - Novel chimeric promoters - Google Patents
Novel chimeric promoters Download PDFInfo
- Publication number
- WO2002000897A3 WO2002000897A3 PCT/US2001/020123 US0120123W WO0200897A3 WO 2002000897 A3 WO2002000897 A3 WO 2002000897A3 US 0120123 W US0120123 W US 0120123W WO 0200897 A3 WO0200897 A3 WO 0200897A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novel chimeric
- chimeric promoters
- enhancers
- chimeric promoter
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001268716A AU2001268716A1 (en) | 2000-06-23 | 2001-06-21 | Novel chimeric promoters |
EP01946703A EP1297146A2 (en) | 2000-06-23 | 2001-06-21 | Novel chimeric promoters |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21382900P | 2000-06-23 | 2000-06-23 | |
US60/213,829 | 2000-06-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002000897A2 WO2002000897A2 (en) | 2002-01-03 |
WO2002000897A3 true WO2002000897A3 (en) | 2002-08-15 |
Family
ID=22796670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/020123 WO2002000897A2 (en) | 2000-06-23 | 2001-06-21 | Novel chimeric promoters |
Country Status (4)
Country | Link |
---|---|
US (1) | US7074590B2 (en) |
EP (1) | EP1297146A2 (en) |
AU (1) | AU2001268716A1 (en) |
WO (1) | WO2002000897A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7134459B2 (en) * | 2003-06-12 | 2006-11-14 | Symyx Technologies, Inc. | Methods and apparatus for mixing powdered samples |
US20070178505A1 (en) * | 2006-01-03 | 2007-08-02 | Curt Fischer | Promoter engineering and genetic control |
GB0606190D0 (en) | 2006-03-28 | 2006-05-10 | Isis Innovation | Construct |
JP5298134B2 (en) | 2007-11-01 | 2013-09-25 | パーシード セラピューティクス リミテッド ライアビリティ カンパニー | Immunosuppressive polypeptides and nucleic acids |
KR100958293B1 (en) * | 2008-03-27 | 2010-05-19 | 단국대학교 산학협력단 | Allosteric trans?splicing group I ribozyme whose activity of target-specific RNA replacement is controlled by theophylline |
ES2540753T3 (en) * | 2012-09-24 | 2015-07-13 | Lonza Biologics Plc. | Expression vectors comprising cytomegalovirus promoter and amplifier chimeric sequences |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5641665A (en) * | 1994-11-28 | 1997-06-24 | Vical Incorporated | Plasmids suitable for IL-2 expression |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4762780A (en) | 1984-04-17 | 1988-08-09 | The Regents Of The University Of California | Method and composition for screening and diagnosing "HCMV" |
DE3431140A1 (en) | 1984-08-24 | 1986-03-06 | Behringwerke Ag, 3550 Marburg | ENHANCER FOR EUKARYOTIC EXPRESSION SYSTEMS |
CA1341482C (en) | 1984-10-31 | 2005-05-10 | Paul A. Luciw | Process for preparing fragments of aids-associated retroviruses |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US5866363A (en) | 1985-08-28 | 1999-02-02 | Pieczenik; George | Method and means for sorting and identifying biological information |
US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
US5824469A (en) | 1986-07-17 | 1998-10-20 | University Of Washington | Method for producing novel DNA sequences with biological activity |
US5273876A (en) | 1987-06-26 | 1993-12-28 | Syntro Corporation | Recombinant human cytomegalovirus containing foreign gene |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
US5512463A (en) | 1991-04-26 | 1996-04-30 | Eli Lilly And Company | Enzymatic inverse polymerase chain reaction library mutagenesis |
US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6165793A (en) | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
US5514588A (en) | 1994-12-13 | 1996-05-07 | Exxon Research And Engineering Company | Surfactant-nutrients for bioremediation of hydrocarbon contaminated soils and water |
US5958672A (en) | 1995-07-18 | 1999-09-28 | Diversa Corporation | Protein activity screening of clones having DNA from uncultivated microorganisms |
US6057103A (en) | 1995-07-18 | 2000-05-02 | Diversa Corporation | Screening for novel bioactivities |
US6030779A (en) | 1995-07-18 | 2000-02-29 | Diversa Corporation | Screening for novel bioactivities |
US6168919B1 (en) | 1996-07-17 | 2001-01-02 | Diversa Corporation | Screening methods for enzymes and enzyme kits |
US6004788A (en) | 1995-07-18 | 1999-12-21 | Diversa Corporation | Enzyme kits and libraries |
US6117676A (en) * | 1995-07-27 | 2000-09-12 | Srl, Inc. | Transfected human amniotic cells and method for producing a gene product |
WO1997007206A1 (en) | 1995-08-11 | 1997-02-27 | Okkels, Jens, Sigurd | Method for preparing polypeptide variants |
US5962258A (en) | 1995-08-23 | 1999-10-05 | Diversa Corporation | Carboxymethyl cellulase fromthermotoga maritima |
US6489145B1 (en) | 1996-07-09 | 2002-12-03 | Diversa Corporation | Method of DNA shuffling |
US5939250A (en) | 1995-12-07 | 1999-08-17 | Diversa Corporation | Production of enzymes having desired activities by mutagenesis |
US5814473A (en) | 1996-02-09 | 1998-09-29 | Diversa Corporation | Transaminases and aminotransferases |
US6171820B1 (en) | 1995-12-07 | 2001-01-09 | Diversa Corporation | Saturation mutagenesis in directed evolution |
US5962283A (en) | 1995-12-07 | 1999-10-05 | Diversa Corporation | Transminases and amnotransferases |
US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
US20030215798A1 (en) | 1997-06-16 | 2003-11-20 | Diversa Corporation | High throughput fluorescence-based screening for novel enzymes |
US5830696A (en) | 1996-12-05 | 1998-11-03 | Diversa Corporation | Directed evolution of thermophilic enzymes |
US5965408A (en) | 1996-07-09 | 1999-10-12 | Diversa Corporation | Method of DNA reassembly by interrupting synthesis |
AU1367897A (en) | 1996-01-10 | 1997-08-01 | Novo Nordisk A/S | A method for in vivo production of a mutant library in cells |
US5942430A (en) | 1996-02-16 | 1999-08-24 | Diversa Corporation | Esterases |
US5958751A (en) | 1996-03-08 | 1999-09-28 | Diversa Corporation | α-galactosidase |
US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
US5789228A (en) | 1996-05-22 | 1998-08-04 | Diversa Corporation | Endoglucanases |
AU3571797A (en) | 1996-06-17 | 1998-01-07 | Fox Chase Cancer Center | Nucleic acid molecule for enhancing gene expression |
US5877001A (en) | 1996-06-17 | 1999-03-02 | Diverso Corporation | Amidase |
US5763239A (en) | 1996-06-18 | 1998-06-09 | Diversa Corporation | Production and use of normalized DNA libraries |
CA2257863A1 (en) | 1996-06-19 | 1997-12-24 | Diversa Corporation | Thermostable phosphatases |
US5939300A (en) | 1996-07-03 | 1999-08-17 | Diversa Corporation | Catalases |
US6156567A (en) | 1996-07-03 | 2000-12-05 | Merial | Truncated transcriptionally active cytomegalovirus promoters |
JP2001504325A (en) | 1996-09-27 | 2001-04-03 | マキシジェン,インコーポレイテッド | A method for optimization of gene therapy by recursive sequence shuffling and selection |
EP0963434A4 (en) | 1996-09-27 | 2000-10-25 | Maxygen Inc | Methods for optimization of gene therapy by recursive sequence shuffling and selection |
US6200959B1 (en) * | 1996-12-04 | 2001-03-13 | Powerject Vaccines Inc. | Genetic induction of anti-viral immune response and genetic vaccine for filovirus |
DE69733322T2 (en) | 1996-12-06 | 2006-02-02 | Diversa Corp., San Diego | Glycosidase ENZYMES |
WO1998028416A1 (en) | 1996-12-20 | 1998-07-02 | Novo Nordisk A/S | In vivo recombination |
KR100570935B1 (en) | 1997-01-17 | 2006-04-13 | 맥시겐, 인크. | Evolution of whole cells and organisms by recursive sequence recombination |
CN1252100A (en) | 1997-02-13 | 2000-05-03 | 唐化学原料公司 | Recombinant haloaliphatic dehalogenases |
DK1015575T3 (en) | 1997-03-18 | 2010-08-23 | Novozymes As | Shuffling of heterologous DNA sequences |
DE69840382D1 (en) | 1997-03-18 | 2009-02-05 | Novozymes As | METHOD FOR THE PRODUCTION OF A LIBRARY THROUGH DNA SHUFFLING |
KR20000076363A (en) | 1997-03-18 | 2000-12-26 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | An in vitro method for construction of a dna library |
US6153410A (en) | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
DE69826604D1 (en) | 1997-04-22 | 2004-11-04 | Gist Brocades Bv | METHOD FOR THE FERMENTATIVE PRODUCTION OF DEACYLATED CEPHALOSPORINES |
US5948666A (en) | 1997-08-06 | 1999-09-07 | Diversa Corporation | Isolation and identification of polymerases |
US5876997A (en) | 1997-08-13 | 1999-03-02 | Diversa Corporation | Phytase |
US6610528B1 (en) | 1997-08-26 | 2003-08-26 | Diversa Corporation | Microbial enrichment using a container having a plurality of solid support particles |
CA2315819A1 (en) | 1997-10-15 | 1999-04-22 | Diversa Corporation | Screening for novel compounds which regulate biological interactions |
WO1999021979A1 (en) | 1997-10-28 | 1999-05-06 | Maxygen, Inc. | Human papillomavirus vectors |
EP1030861A4 (en) | 1997-10-31 | 2001-09-05 | Maxygen Inc | Modification of virus tropism and host range by viral genome shuffling |
KR20010032861A (en) | 1997-12-08 | 2001-04-25 | 캘리포니아 인스티튜트 오브 테크놀로지 | Method for creating polynucleotide and polypeptide sequences |
EP0977895A1 (en) | 1997-12-30 | 2000-02-09 | MARTIN, William John | Stealth virus nucleic acids and related methods |
EP1045919A1 (en) | 1998-01-16 | 2000-10-25 | Genzyme Corporation | Novel promoter elements for persistent gene expression |
JP2002507392A (en) | 1998-02-11 | 2002-03-12 | マキシジェン, インコーポレイテッド | Optimization of immunomodulatory properties of gene vaccines |
-
2001
- 2001-06-21 WO PCT/US2001/020123 patent/WO2002000897A2/en not_active Application Discontinuation
- 2001-06-21 AU AU2001268716A patent/AU2001268716A1/en not_active Abandoned
- 2001-06-21 EP EP01946703A patent/EP1297146A2/en not_active Withdrawn
- 2001-06-21 US US09/886,942 patent/US7074590B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5641665A (en) * | 1994-11-28 | 1997-06-24 | Vical Incorporated | Plasmids suitable for IL-2 expression |
Non-Patent Citations (3)
Title |
---|
ALCENDOR D.J. ET AL.: "Analysis of the Rhesus cytomegalovirus Immeadiate-Early gene promoter", VIROLOGY, vol. 194, 1993, pages 815 - 821, XP002198528 * |
CHAPMAN B S ET AL: "EFFECT OF INTRON A FROM HUMAN CYTOMEGALOVIRUS (TOWNE) IMMEDIATE- EARLY GENE ON HETEROLOGOUS EXPRESSION IN MAMMALIAN CELLS", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 19, no. 14, 25 July 1991 (1991-07-25), pages 3979 - 3986, XP000569788, ISSN: 0305-1048 * |
DATABASE GENBANK [online] 10 February 1999 (1999-02-10), "Human cytomegalovirus strain AD169 complete genome.", XP002198529, Database accession no. X17403 * |
Also Published As
Publication number | Publication date |
---|---|
US7074590B2 (en) | 2006-07-11 |
WO2002000897A2 (en) | 2002-01-03 |
EP1297146A2 (en) | 2003-04-02 |
AU2001268716A1 (en) | 2002-01-08 |
US20020081708A1 (en) | 2002-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2433901A (en) | Chimeric natriuretic peptides | |
EP2345671B8 (en) | Optimized fc variants and methods for their generation | |
AU1292700A (en) | Immune cells having predefined biological specificity, comprising chimeric t cell receptor | |
AU2002236096A1 (en) | Salmonella promoter for heterologous gene expression | |
AU3358999A (en) | Chimeric adenoviral vectors for targeted gene delivery | |
AU7131600A (en) | Acid-inducible promoters for gene expression | |
ZA9810915B (en) | Optimization of cells for endogenous gene activation. | |
WO2004005221A3 (en) | Benzoate- and anthranilate-inducible promoters | |
AU2001241682A1 (en) | Gene expression system based on chimeric receptors | |
WO2002000897A3 (en) | Novel chimeric promoters | |
WO2001049721A3 (en) | Bacterial genes and proteins that are essential for cell viability and their uses | |
WO2000004051A3 (en) | Growth differentiation factor promoter and uses therefor | |
WO2002031121A3 (en) | Improvement of endothelial cell-cell cohesion | |
AU2001247467A1 (en) | Peptides targeting specifically tumor-derived endothelial cells | |
AU2001278700A1 (en) | Method of culturing human chondrocytes | |
AU2001266740A1 (en) | Promoters for regulated gene expression | |
AU7116700A (en) | Thermus promoters for gene expression | |
AU2001270614A1 (en) | Chimeric promoters for controlling expression in smooth muscle cells | |
EP1048733A3 (en) | Plant promoters | |
AU2003241299A1 (en) | Novel prostate tumor-specific promoter | |
AU5561599A (en) | Dna promoter sequence for gene expression | |
AU2003261922A1 (en) | Secretory or membrane-binding chimeric protein | |
IL142680A0 (en) | Minimal promoters and uses thereof | |
ZA200408194B (en) | Recombinant yeast cells increasing the synthesis of resveratrol during fermentation. | |
AU2003282465A8 (en) | Isolated mammalian membrane protein genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001946703 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001946703 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001946703 Country of ref document: EP |